Targeting the development and effector functions of TH17 cells
- PMID: 18083530
- DOI: 10.1016/j.smim.2007.10.016
Targeting the development and effector functions of TH17 cells
Abstract
T helper (TH) cells can assume different phenotypes characterized by the secretion of distinct effector molecules. Interferon-gamma producing TH1 and IL-4 producing TH2 cells have long been recognized as important mediators of host defense, whereas regulatory T cells are known to suppress T cell responses. Recently, TH17 cells were characterized as a novel CD4(+) subset that preferentially produces IL-17, IL-17F, and IL-22 as the signature cytokines. TH17 cells appear to play a critical role in sustaining the inflammatory response and their presence is closely associated with autoimmune disease, which makes them an attractive therapeutic target. In this review, we focus on the mechanisms that regulate the differentiation of naive T cells into TH17 cells and on TH17 effector cytokines, as they represent opportunities for therapeutic intervention.
Similar articles
-
IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.Int Immunol. 2007 Jun;19(6):695-702. doi: 10.1093/intimm/dxm045. Epub 2007 May 9. Int Immunol. 2007. PMID: 17493959
-
The Th17/Treg imbalance in patients with acute coronary syndrome.Clin Immunol. 2008 Apr;127(1):89-97. doi: 10.1016/j.clim.2008.01.009. Epub 2008 Feb 21. Clin Immunol. 2008. PMID: 18294918
-
The link between IL-23 and Th17 cell-mediated immune pathologies.Semin Immunol. 2007 Dec;19(6):372-6. doi: 10.1016/j.smim.2007.10.012. Epub 2007 Dec 3. Semin Immunol. 2007. PMID: 18319054 Review.
-
Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627. Curr Opin Gastroenterol. 2009. PMID: 19448533 Review.
-
Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.Eur J Immunol. 2009 Oct;39(10):2840-9. doi: 10.1002/eji.200839070. Eur J Immunol. 2009. PMID: 19637224
Cited by
-
Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms.Mucosal Immunol. 2012 May;5(3):320-31. doi: 10.1038/mi.2012.12. Epub 2012 Feb 22. Mucosal Immunol. 2012. PMID: 22354319 Free PMC article.
-
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.J Clin Cell Immunol. 2016 Apr;7(2):400. doi: 10.4172/2155-9899.1000400. Epub 2016 Mar 22. J Clin Cell Immunol. 2016. PMID: 27308096 Free PMC article.
-
T-helper cells in the etiopathogenesis of periodontal disease: A mini review.J Indian Soc Periodontol. 2011 Jan;15(1):4-10. doi: 10.4103/0972-124X.82255. J Indian Soc Periodontol. 2011. PMID: 21772714 Free PMC article.
-
Structure and signalling in the IL-17 receptor family.Nat Rev Immunol. 2009 Aug;9(8):556-67. doi: 10.1038/nri2586. Epub 2009 Jul 3. Nat Rev Immunol. 2009. PMID: 19575028 Free PMC article. Review.
-
T cell epitope: friend or foe? Immunogenicity of biologics in context.Adv Drug Deliv Rev. 2009 Sep 30;61(11):965-76. doi: 10.1016/j.addr.2009.07.001. Epub 2009 Jul 18. Adv Drug Deliv Rev. 2009. PMID: 19619593 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials